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The toroviruses, Berne virus (BEV) and Breda virus (BRV), are recognized pathogens of horses and cattle, respectively.
Torovirus-like particles (TVLPs) that are immunologically related to BRV have been reported as etiological agents of gastroen-
teritis in humans. Of the toroviruses, only BEV has been shown to replicate in cell culture. Hence, these agents can be
routinely detected only by electron microscopy (EM), although serological testing has been used as well. Our studies have
provided supporting evidence that the TVLPs detected in the stool specimens of pediatric patients with gastroenteritis are
human toroviruses. By EM, these particles are morphologically similar to BEV and BRV. Thin-section electron microscopy
revealed that TVLPs contain toroidal-shaped nucleocapsids. Viruses purified from human fecal specimens agglutinate rabbit
erythrocytes. BRV antiserum as well as convalescent sera from patients with gastroenteritis whose stools contain TVLPs
were shown to contain antibodies that react with purified TVLPs as demonstrated by hemagglutination inhibition, immunoelec-
tron microscopy, and immunoblotting. RNA extracted from partially purified TVLP preparations is amplifiable by RT-PCR
using primers bracketing a 219-base region at the 3* end of the Berne virus genome. Sequence analysis of amplicons from
five isolates showed a high degree of identity with the corresponding BEV sequence. q 1997 Academic Press
INTRODUCTION cles measure 120 to 140 nm at their largest diameter
(Horzinek et al., 1987; Weiss and Horzinek, 1987). In the
The torovirus prototype, Berne virus (BEV), was iso-
mature virion, the helical nucleocapsid is torus-shaped,
lated in 1972 from the rectal swab of a diarrheic horse
from which the virus gets its name. However, the nucleo-
in Berne, Switzerland (Weiss et al., 1983). A decade later,
capsid may also exist in the form of a rod or crescent in
a morphologically similar virus, called Breda virus (BRV),
a subset of particles (Weiss et al., 1983).
was found in Breda, Iowa, in the stools of neonatal calves
Purified BRV particles were found to hemagglutinate
with diarrhea (Woode et al., 1982). Other BRV isolates
mouse and rat erythrocytes, whereas BEV particles hem-
were later found in feces from a colostrum-deprived calf
agglutinate human O, rabbit, and guinea pig erythrocytes
in Iowa and in the stools of diarrheic calves in Ohio
(Horzinek et al., 1987). These viruses also have cross-
(Woode et al., 1985; Weiss and Horzinek, 1987). It was
reacting antigens as evidenced by immunoelectron mi-
found that the two enteric pathogens, BEV and BRV, are
croscopy (IEM) (Beards et al., 1986) and enzyme-linked
morphologically and antigenically related (Weiss et al.,
immunosorbant assay (ELISA) (Weiss et al., 1983; Brown
1983), and as such they were initially proposed to com- et al., 1987; Koopmans et al., 1989). Viral structural pro-
prise a separate family (Weiss and Horzinek, 1987; Horzi- teins include the phosphorylated nucleocapsid protein,
nek et al., 1987). However, recent analysis of the genome N (molecular mass 20 kDa), the envelope protein, M (mo-
and replication strategy of BEV indicates that toroviruses lecular mass 25 kDa), and the glycoprotein peplomer, S,
are more closely related to the coronaviruses (Snijder et which migrates between 75 and 100kda because it has
al., 1991, 1990c). Thus, BEV and BRV are now classified variable degrees of N-glycosylation (Horzinek et al., 1986;
as members of the genus torovirus in the family Corona- Weiss and Horzinek, 1987).
viridae (Cavanagh et al., 1994, Cavanagh, 1997). The organization of the BEV genome and its replication
Morphologically, toroviruses are composed of an elon- strategy have been described by Snijder et al. (1990a).
gated tubular nucleocapsid of helical symmetry, sur- The BEV genome has been shown to be a single-
rounded by an envelope bearing peplomers. These parti- stranded positive sense RNA of approximately 26–28 kb
in length whose organization is similar to that of equine
Human torovirus nucleotide sequence has been deposited with Gen- arterivirus (EAV), avian infectious bronchitis virus, and
Bank under Accession No. AF024539. mouse hepatitis virus, with whom there is evidence of1 To whom correspondence and reprint requests should be ad-
common ancestry (Horzinek et al., 1987; Snijder and Hor-dressed at Division of Microbiology, The Hospital for Sick Children,
zinek, 1993; Snijder et al., 1994). In addition, the se-555 University Avenue, Toronto, Ontario M5G 1X8. Canada. Fax: (416)
813-6257. quence of 269 nt, upstream of the poly(A) tail of the BRV
1580042-6822/97 $25.00
Copyright q 1997 by Academic Press
All rights of reproduction in any form reserved.
AID VY 8879 / 6a54$$$401 11-10-97 12:08:39 viras AP: VY
159CHARACTERIZATION OF HUMAN TOROVIRUS
genome has been determined and shown to be 93% resin, and heat-polymerized overnight. Ultrathin sections
(80 nm) were cut on a Reichert Ultracut E ultramicrotomeidentical to that of BEV (Koopmans et al., 1991).
Evidence that toroviruses could also be potential hu- (Leica Canada Inc.), collected on copper grids, and
stained with uranyl acetate and Reynolds lead citrate.man pathogens initially came from Beards et al. (1984)
who reported the appearance by EM of particles similar The sections were examined by EM at a magnification
of 70,0001 (Quan and Doane, 1983).to BEV and BRV in the fecal specimens of children with
diarrhea. These agents, termed human torovirus-like par-
Immunoelectron microscopyticles (TVLPs), have since been proposed to be related
to BEV and BRV on the basis of morphological and sero-
Immune electron microscopy was performed using ei-
logical similarities. (Beards et al., 1986). Further support
ther convalescent serum from BRV-infected calves
for the existence of a human torovirus was obtained
(baBRV; provided by G. Woode, Texas A&M), or paired
when human stool specimens which were found to con-
acute and convalescent sera from patients with gastro-
tain TVLPs by EM were shown to be reactive in a toro-
enteritis whose stools were positive for TVLPs by EM
virus-specific ELISA based on BRV antiserum (Koopmans
(a/c paired sera). The sera were heat inactivated at 567
et al., 1993).
for 30 min, diluted at 1:50 with 1% ammonium acetate,
The above studies have provided good evidence that
mixed with an equal volume of purified TVLP prepara-
the TVLPs found in the stools of pediatric patients with
tions or control preparations, and incubated for 2 h at
gastroenteritis are human toroviruses. However, there
377. The preparations were centrifuged at 9000 g for 15
remains a need to further characterize the biochemical,
min at room temperature. The pellets were resuspended
serological, and molecular properties of human TVLPs.
in 1% ammonium acetate and examined by EM at a mag-
In this study, we report on the purification and character-
nification of 50,0001 (Kapikian et al., 1972; Woode et al.,
ization of human torovirus from the fecal specimens of
1985). Control specimens included a purified rotavirus-
patients with gastroenteritis.
positive fecal sample, and a purified sample from a pa-
tient with diarrhea in which no viruses could be detected
MATERIALS AND METHODS by EM.
Electron microscopy
Hemagglutination assay
Crude diarrheic stool samples suspended in 1% am-
Serial twofold dilutions of purified TVLP preparationsmonium acetate, or purified TVLP preparations, were
were made in 50-ml volumes of veronal buffered salinestained with 2% phosphotungstic acid and examined by
(VBS) (Oxoid, England) in V-shaped-bottom microtiternegative contrast electron microscopy (EM) on a Phillips
plates. For the hemagglutination assay (HA) 50 ml of aEM 300 at a magnification of 50,0001 (Middleton et al.,
0.5% suspension of either human O, rabbit, guinea pig,1977).
horse, or sheep erythrocytes in VBS was added to each
well. The plates were incubated for 2 h at room tempera-Purification of TVLPs
ture and examined for hemagglutination (Woode et al.,
Stool specimens obtained from patients with gastroen- 1985). The reciprocal of the final dilution of the TVLP
teritis whose stools were found to be positive for TVLPs preparation showing complete hemagglutination was de-
by EM were diluted with an equal volume of 1% ammo- fined as the titer in HA units. A purified fecal specimen
nium acetate (w/v) and clarified by centrifugation at 9000 documented to be positive for rotavirus by EM and two
g for 20 min at 47. The supernatants were layered on a stool sample preparations from patients with diarrhea in
4-ml cushion of 25% Histopaque-1077 (Sigma, St. Louis, which no viruses could be detected by EM were tested
MO) in 1% ammonium acetate in 12-ml Beckman polyal- in parallel as controls.
lomer ultracentrifuge tubes. The specimens were then
centrifuged in a Beckman SW41Ti rotor at 100,000 g for Preparation of guinea pig antisera to TVLPs
90 min at 47. The pellets were resuspended in 1% ammo-
Two young adult male guinea pigs were inoculatednium acetate and stored at 47. All control stool specimens
subcutaneously once a week for 5 successive weeksused in this study were processed in a similar manner.
with a 2:1 suspension of purified TVLPs in Freund’s in-
Thin-section electron microscopy complete adjuvant. Pre- and postimmunization sera were
collected.
Purified TVLP preparations were subjected to ultracen-
trifugation at 100,000 g for 2 h at 47, and the pellets were Hemagglutination inhibition
fixed in 2% gluteraldehyde for 24 h. After postfixing with
osmium tetroxide overnight, the pellets were dehydrated The panel of sera tested for hemagglutination inhibi-
tion (HI) included guinea pig preimmune (gpPI) andin acetone, infiltrated and embedded in Epon araldite
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FIG. 1. (a and b) Electron micrographs of a purified fecal specimen showing torus (arrow)-, crescent (arrowhead)-, and rod (double arrowhead)-
shaped human TVLPs. (c) TVLPs can be distinguished from enteric coronaviruses whose spikes are more prominent and readily discernable. Bars
 100 nm.
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FIG. 2. Electron micrographs of human torovirus particles in ultrathin sections of a purified TVLP preparation. (a) Elliptical and crescent-shaped
particles, (b) cross section of torus showing one electron dense area, (c) elliptical particle showing one electron dense area, (d) elliptical particle
and cross section of torus showing two electron dense areas, (e) elliptical particle and rod-shaped particle, (f) cross section of crescent-shaped
particle. Arrows indicate designated particles and structures. Bars  100 nm.
hyperimmune (gpHI) sera, baBRV serum, and human Sodium dodecyl sulfate–polyacrylamide gel
electrophoresis (SDS–PAGE) and immunoblottinga/c paired sera. Prior to use in the HI assay, the serum
aliquots were absorbed with an equal volume of
Purified TVLP preparations were subjected to SDS–packed rabbit erythrocytes for 1 h at 47 to remove non-
PAGE on a 15% resolving gel and a 4% stacking gel. Thespecific hemagglutinating activity. Twofold serial dilu-
gels were either stained with Coomassie brilliant bluetions of each serum were made in 25-ml volumes of
R250 or used to perform an immunoblot procedure (Sam-VBS in V-bottomed microtiter plates. Four HA units of
brook et al., 1989). For the immunoblot, the proteins pres-partially purified TVLP preparations in 25 ml of VBS
ent in the SDS–PAGE gel were transferred electrophoret-was then added to each well and the plates were incu-
ically to a polyvinylidene fluoride (PVDF) nylon membranebated for 1 h at room temperature. A 50-ml volume of
(Millipore, Bedford, MA) for 90 min at 100 V. The mem-a 0.5% suspension of rabbit erythrocytes in VBS was
branes were washed and blocked overnight in a solutionadded to each well containing TVLP preparations. The
of 5% skim milk and 5% goat serum in Tris-buffered salineplates were incubated for 2 h at room temperature and
containing 0.5% Tween-20 (TBST) (for blots with a/cexamined for hemagglutination (Woode et al., 1985).
paired sera) or 1% pig gelatin in TBST (for blots withControl hemagglutination inhibition testing was per-
baBRV serum). The membranes were then incubated forformed using four HA units of a purified rotavirus prep-
4 h at room temperature in a 1:2000 dilution of eitheraration. Serum aliquots were absorbed with human
human a/c paired sera in 1% skim milk in TBST, or baBRVO erythrocytes. These HI assays were performed as
serum in 1% pig gelatin in TBST. The membranes wereabove, except that a 0.5% suspension of human group
washed and incubated for 2 h at room temperature inO erythrocytes in VBS was added to all wells con-
taining rotavirus preparations. a 1:1000 dilution of biotinylated murine anti-human IgG
AID VY 8879 / 6a54$$$402 11-10-97 12:08:39 viras AP: VY
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FIG. 3. Immunoelectron microscopy of a purified TVLP preparation with (a) human acute serum and (b) human convalescent serum. Bars  100
nm.
(Sigma, Mississauga, Ontario, Canada) in 1% skim milk PCR. For each TVLP-positive sample assayed, we in-
cluded a negative control (ddH2O) and a second con-in TBST (for blots with a/c paired sera), or biotinylated
goat anti-bovine IgG (Sigma, Mississauga, ON) in 1% pig trol consisting of RNA extracted from either a stool
sample without any detectable gastroenteritis virusesgelatin in TBST (for blots with baBRV serum). Following
further washing, the membranes were incubated for 45 by EM (8 assays) or RNA extracted from samples con-
taining rotavirus (6 assays) or enteric coronavirus (4min at room temperature in ImmunoPure ABC peroxidase
staining reagents (Pierce, Rockford, IL), treated for 1 min assays). Oligonucleotide primers (General Synthesis
and Diagnostics, Toronto, Ontario, Canada) were de-with ECL horseradish peroxidase detection reagent (Am-
ersham Life Science, Oakville, Ontario, Canada), and ex- signed from the 3* end of the BEV genome (DDBJ Ac-
cession No. D00563). The sense primer (5*TAATGG-posed to Kodak X-Omat AR imaging film for 15–30 s.
CACTGAAGACTC3*) and the antisense primer (5*ACA-
RNA extraction TAACATCTTACATGG3*) bracketed a genome fragment
of 219 nucleotides, which included the 3* end of the NFecal specimens were diluted in an equal volume of
phosphate-buffered saline (w/v) and clarified by centrifu- protein coding region and most of the 3* noncoding
region upstream of the poly(A) tail.gation at 9000 g for 15 min at 47. The supernatant was
transferred to a new tube and centrifuged at 12,000 g The RT and PCR reaction mixtures were set up in
another isolated room, using dedicated micropipettersfor 15 min at 47. In a separate room, using dedicated
micropipetters and aerosol-resistant tips, viral RNA was and aerosol-resistant tips. Reactions were then per-
formed in a third room designated for PCR amplification.extracted from the partially purified supernatant using
TRIzol Reagent (Gibco BRL, Burlington, Ontario, Canada) For the RT reaction, an RNA aliquot was thawed on ice,
and incubated for 5 min at 657. The RNA was added toaccording to the manufacturer’s protocol. Each RNA pel-
let was resuspended in 10 ml of DNase free, RNase free 10 ml of the RT mixture containing 5 mM MgCl2 , 10 mM
Tris–HCl (pH 8.3), 50 mM KCl, 1.25 mM (each) dATP,double distilled water (5 prime 3 prime Inc., Boulder, CO)
and stored at 0807. dCTP, dGTP, and dTTP (Promega, Madison, WI), 2.6 mM
random hexamer primers, 20 U RNase Guard (Gibco,
RT-PCR BRL), and 50 U of Moloney murine leukemia virus reverse
transcriptase (Gibco BRL). The reaction mixture wasA total of 18 stool samples positive for TVLPs by EM
were tested for the presence of torovirus RNA by RT- overlaid with sterile mineral oil and incubated at room
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TABLE 1 ation at 947 for 2 min, the reaction was subjected to 35
cycles consisting of denaturation at 957 for 40 s, anneal-Immunoelectron Microscopy (IEM) and Hemagglutination Inhibition
ing at 507 for 1 min, and extension at 727 for 1 min 30 s.(HI) Results for Two Human Fecal Specimens Found to be Positive
for Torovirus-Like Particles by Electron Microscopy (TVLP 1 and 2) Reactions were then incubated at 727 for 10 min and
held at 47. Reactions were analyzed by electrophoresis in
IEM HI a 1.2% agarose gel, subsequently stained with ethidium
bromide, and viewed under a UV transilluminator.Sera TVLP1 TVLP2 Rota Neg TVLP1 TVLP2 Rota
hu1 a 0 0 0 0 1:8 1:8 1:8 Cloning and DNA sequencing
c /// // 0 0 1:128 1:64 1:8
PCR products were purified using the Wizard PCRhu2 a 0// 0 0 0 1:16 1:8 1:8
c / / 0 0 1:32 1:32 1:8 Preps DNA Purification System (Promega, Madison, WI).
hu3 a 0 0 0 0 1:8 1:8 1:4 Amplicons were then cloned into a pCR-Script Amp SK/
c / / 0 0 1:32 1:32 1:8 cloning vector, and transformed into Epicurian coli XL1-
hu4 a 0 0 0 0 1:8 1:4 1:8
blue MRF* Kan supercompetent cells using the pCR-c /// /// 0 0 1:64 1:64 1:16
Script Amp SK/ cloning kit (Stratagene, La Jolla, CA) ashu5 a 0 0 0 0 1:16 1:8 1:8
c // / 0 0 1:128 1:64 1:8 per the manufacturer’s recommendations. Clones were
hu6 a 0 0 0 0 1:8 1:8 1:4 screened by PCR using the same primers as above. Plas-
c // // 0 0 1:64 1:64 1:4 mids containing the PCR insert were purified from LB
hu7 a 0 0 0 0 1:8 1:16 1:8
broth cultures using the Wizard Miniprep DNA purifica-c / // 0 0 1:32 1:64 1:8
tion system (Promega) and sequenced using the protocolhu8 a 0 0 0 0 1:8 1:8 1:4
c // // 0 0 1:64 1:64 1:8 for direct label incorporation in the fmol DNA sequencing
hu9 a 0 0 0 0 1:16 1:8 1:8 system (Promega) according to the manufacturer’s rec-
c // / 0 0 1:64 1:32 1:8 ommendations. Sequence data were analyzed using the
hu10 a 0 0// 0 0 1:8 1:4 1:8
computer program GCG version 8 (Genetics Computera / / 0 0 1:32 1:8 1:4
Group Inc., Madison, WI). As an additional precautionhu11 a 0 0 0 0 1:16 1:8 1:4
c /// /// 0 0 1:128 1:128 1:8 against plasmid contamination of PCR reactions, all clon-
hu12 a 0 0 0 0 1:8 1:8 1:8 ing and sequencing assays were undertaken only after
c / // 0 0 1:32 1:64 1:8 the RT-PCR experiments on stool samples had been
baBRV /// // 0 0 1:32 1:16 1:8
completed.gp1 PI 1:8 1:8 1:8
HI ND 1:64 1:64 1:16
gp2 PI 1:8 1:8 1:8 RESULTS
HI ND 1:64 1:32 1:16
Electron microscopy and thin-section electron
Note. Controls included one rotavirus-positive specimen (Rota), and microscopy
one patient specimen in which no virus was found by electron micros-
copy (Neg). Sera used in these assays included 12 human acute and Human TVLPs detected by negative contrast electron
convalescent paired sera (hu a or hu c), one bovine anti-Breda virus
microscopy were morphologically similar to BEV and BRVserum (baBRV), and two guinea pig preimmune (gpPI) and hyperim-
in that they exhibited crescent-, torus-, and rod-shapedmune (gpHI) antisera to TVLPs. 0, no aggregates per field; /, 2–3
clumped particles per field: //, 2–3 aggregates per field: ///, many conformations (Figs. 1a and 1b). The particles measured
aggregates per field, ND: not determined. For HI, a four-fold or more between 100 and 120 nm at their largest diameter. The
increase in titre between the acute and convalescent sera was consid- envelope and peplomers on these particles remained
ered to be a positive HI result, representing sero conversion.
intact throughout the purification process, and these fea-
tures were readily discernible. The peplomers measured
approximately 10 nm in length. TVLPs can be readilytemperature for 10 min. The RT reaction was performed
in a Perkin-Elmer (Mississauga, Ontario, Canada) ther- distinguished from enteric coronaviruses which are
somewhat larger in size and whose peplomer spikes aremal cycler at 427 for 30 min, 997 for 5 min, and then held
at 57 for 5 min. longer and more prominent (Fig. 1c).
When examined by EM, ultrathin sections of purifiedFor the PCR reaction, 10 ml of the RT reaction was
added to the PCR mixture containing 1 mM MgCl2 , 8 virus preparations demonstrated a number of elliptical
particles enclosing hollow torus-shaped cores (Figs. 2a,mM Tris–HCl (pH 8.3), 40 mM KCl, 2.5 U Amplitaq DNA
polymerase (Perkin-Elmer Cetus and Applied Biosystems 2d, and 2e), structures corresponding to cross sections
of these particles showing either one or two electronInc., Mississauga, Ontario, Canada), and 50 pmol of each
primer. The total volume of the PCR reaction was 50 ml. dense areas bound by the envelope (Figs. 2b–2d, and
2f), as well as sections showing full rod or crescentThe reaction was overlaid with sterile mineral oil and
amplified in a Perkin-Elmer thermal cycler. After denatur- shapes (Figs. 2a and 2e). The particles representing the
AID VY 8879 / 6a54$$$402 11-10-97 12:08:39 viras AP: VY
164 DUCKMANTON ET AL.
FIG. 4. (a) SDS–polyacrylamide gel electrophoresis and (b) corresponding immunoblot of a purified TVLP preparation using human acute (huA)
and convalescent (huC) serum and murine anti-human antiserum (mah).
whole virion measured 100 to 120 nm in diameter and the the consistency of this reaction, 12 partially purified TVLP
preparations from patients with gastroenteritis werenucleocapsid cross sections measured approximately 25
nm in diameter. tested for HA activity with rabbit erythrocytes. Nine of
these had HA titers of 1:640 or greater, and the remainder
Immunoelectron microscopy had titers of 1:40, 1:160, and 1:320. The rotavirus-positive
control specimen was found to agglutinate human groupA total of 12 human a/c paired sera and one baBRV
O erythrocytes (1:320) as previously demonstrated byconvalescent serum were tested for their reactivity with
Spence et al. (1978). Hemagglutination could not be dem-two purified TVLP preparations, a preparation containing
onstrated with the virus-negative control samples (datarotavirus, and a virus-negative preparation. Immunospec-
not shown).ific reactivity was defined by the formation of viral aggre-
A number of sera were tested for their ability to inhibitgates by the convalescent but not the acute serum (Fig.
the hemagglutination of rabbit erythrocytes by purified3). No acute serum was available for comparison with
TVLP preparations, or of human group O erythrocytes bythe baBRV serum. In all cases it was found that the
a rotavirus preparation. Hemagglutination inhibition ofconvalescent sera were immunoreactive with the TVLPs
rabbit erythrocytes by purified TVLPs was shown withwhile the acute sera showed no reactivity (Table 1). The
both of the gpHI sera, and to a lesser extent with thebaBRV serum formed numerous aggregates with both
baBRV serum. The gpPI serum showed negligible activ-TVLP-positive specimens. In all cases, the human acute
ity. The human convalescent sera manifested fourfold orand convalescent sera were not reactive with the control
greater antibody rises in all but two cases compared tospecimens.
the acute sera (Table 1). The rotavirus control antigen
sustained minimal hemagglutination inhibition with allHemagglutination and hemagglutination inhibition
sera tested.
When purified TVLP preparations were examined for
their ability to hemagglutinate the erythrocytes of five SDS–PAGE and immunoblotting
different species, rabbit erythrocytes were agglutinated
to the highest dilution (1:1280) of virus. Hemagglutination When the TVLP preparations were analyzed by SDS–
PAGE, bands with molecular masses of 32, 75, 88, 100,was also observed to a lesser extent with human O eryth-
rocytes (1:40). Minimal activity was observed with the 115, 134, and 141 kDa were detected as shown in Fig.
4. The bands between 75 and 100 kDa are of interest asguinea pig, horse, and sheep erythrocytes. To determine
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FIG. 5. Gel electrophoresis of RT-PCR products amplified using RNA extracted from five TVLP-positive fecal specimens and primers specific for
the 3* noncoding region of the BEV genome. The fecal specimens were collected over a 4-year period: lane 1, 1993; lane 2, 1994; lane 3, 1995;
lanes 4 and 5, 1996. Lanes marked 0 and R represent a negative control (ddH2O) and a rotavirus sample, respectively. DNA mass ladder was
used as the molecular size marker.
they are expected to correspond to the S protein equiva- tained from five different samples (Fig. 5) were cloned
and sequenced. The nucleotide sequences were com-lents of BRV and BEV. To establish whether these bands
are specific for toroviruses, the gels were further ana- pared to that of BEV. These five products were amplified
from fecal specimens taken in 4 different years (1993–lyzed by immunoblot using one baBRV serum and two of
the a/c paired patient sera whose titers to TVLPs were 1996) in order to test for the possibility of genetic varia-
tion among the specimens. Clones were screened bypreviously determined by HI and IEM. The human conva-
lescent serum but not the acute serum reacted consis- PCR using the same primers, and 11 of them (at least 2
clones per sample) were found to contain the 219-basetently with bands between 78 and 90 kDa. The 32-kDa
band was reactive with both the acute and convalescent fragment. These 11 clones were sequenced, and a com-
parison was made with the 3* region of the BEV genome,sera, as well as with the secondary antibody control, and
was therefore considered to be nonspecific. This 32-kDa which includes the 3* end of the N protein gene (Fig. 6).
The nucleotide sequences of each of the five TVLP iso-band was also present in immunoblots using the baBRV
serum, and only limited reactivity of the 78-kDa band with lates were found to be 99% identical to BEV in this area.
For each isolate, there were no discrepancies betweenthis convalescent serum could be demonstrated (data
not shown). the sequences of its clones. However, each isolate had
at least one, but no more than two nucleotide substitu-
RT-PCR tions compared to BEV. All of these substitutions were
Using primers designed from the genome sequence situated in the 3* end of the N gene between nucleotides
of BEV, an amplicon of 219 bases was detected in all of 49 and 61, and none of these mutations caused changes
the 18 TVLP-positive samples tested. Of the 8 control in the predicted amino acid sequence of the N protein.
specimens that were negative for any virus by EM, only
1 was positive by RT-PCR. Of the remaining 10 control DISCUSSION
specimens that contained either rotavirus or enteric coro-
Berne virus propagated in cell cultures and Bredanavirus, one sample containing coronavirus particles
virus purified from stool specimens of infected calvesgave a positive result by RT-PCR. Shown in Fig. 5 are
have been well characterized and are establishedrepresentative amplification products after agarose gel
pathogens of horses and cattle, respectively (Weisselectrophoresis.
and Horzinek, 1987). Particles with morphological fea-
Cloning and sequencing of torovirus-positive RT-PCR tures similar to those of BEV and BRV have been re-
products ported in the fecal specimens of children with diarrhea
(Beards et al., 1984). However, the status of these toro-To assess the nature of the 219-base product obtained
in TVLP-positive specimens by RT-PCR, amplicons ob- virus-like particles as human pathogens remained un-
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FIG. 6. Alignment of the nucleotide sequence from the 3* end of the Berne virus genome (consensus) with that of five human TVLP-positive
samples collected over a 4-year period (a, 1993; b, 1994; c, 1995; d and e, 1996). Nucleotides identical to the consensus sequence are shown as
dots.
clear because they lacked the definitive morphology examination is as of yet unresolved. Furthermore, the
ultrastructure of the virus, as visualized by thin sectionof other iscosahedral gastroenteritis viruses, they
could not be propagated in conventional cell culture, EM, was consistent with that found in BEV infected cells
and BRV infected gut epithelium (Weiss et al., 1983;and they could not be identified by readily available
immunospecific reagents. Nevertheless, the observa- Weiss and Horzinek, 1987). These structures included
particles with enveloped, crescent-shaped cores, as welltion that the TVLPs detected by EM in human stool
specimens were reactive in an ELISA based on BRV as cross-sections through these cores showing the tubu-
lar nucleocapsid surrounded by the envelope.antiserum provided immunospecific evidence that
these agents were toroviruses (Koopmans et al., 1993). Human TVLPs are morphologically pleomorphic and
could not be propagated in cell culture. Therefore, sev-The investigation of TVLPs from patient specimens
was initially compromised by difficulties in obtaining ade- eral independent immunospecific approaches, such as
IEM, HI, and immunoblotting, were used to characterizequate preparations of intact virions. While ultracentrifuga-
tion through sucrose gradients allowed for the purifica- these particles. Beards et al. (1986) observed a serologi-
cal relationship between BEV, BRV, and TVLPs on thetion of immunoreactive particles (Koopmans et al., 1993),
such preparations could not be consistently obtained. basis of IEM studies. Using this method, we demon-
strated instances of seroconversions to human TVLPsThis procedure also appeared to alter the morphology
of some TVLPs and disrupt the peplomer fringes, thereby following infection. Our finding that purified TVLP prepa-
rations manifested strong hemagglutination activity withmaking any biochemical analyses of these particles diffi-
cult to interpret. Thus, an alternative method was de- rabbit erythrocytes led to the design of a hemagglutina-
tion inhibition assay. Seroconversions following torovirussigned to purify TVLPs by sedimentation through a cush-
ion of Ficoll in 1% ammonium acetate. This procedure infection were readily documented using acute/conva-
lescent paired patient sera. HI titers were found to beresulted in highly enriched preparations of intact TVLPs
whose peplomer fringes were well preserved. Although reproducible using TVLP preparations that were either
homologous or heterologous to the patient sera. Thesethese TVLPs should be deemed to be only partially puri-
fied, their preserved morphology suggests that they are results were consistent with those found by IEM for the
respective sera.likely to contain immunoreactive structural proteins.
The morphology of the TVLPs purified from human The immunoblot assays showed that the human con-
valescent sera, but not the acute sera were reactive tofecal specimens provides evidence that these agents are
toroviruses. Human TVLPs closely resembled BEV and a 78- to 90-kDa protein that is present in partially purified
virus preparations. Based on its molecular weight, thisBRV when examined by negative contrast electron mi-
croscopy. These purified particles have the same pleo- protein most likely represents the viral glycoprotein
peplomer, S, which in the case of BEV and BRV migratesmorphic nature as those detected directly in stool speci-
mens. Whether these forms are part of the virus popula- as a band between 75 and 100 kDa due to variable
degrees of glycosylation (Snijder et al., 1990b). The dem-tion or are simply due to drying and staining during EM
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